Season 1, Episode 1 Transcript
This episode of the I SAVE That Podcast is made possible by The Clinician Exchange. The Clinician Exchange is healthcare industry’s hub for clinical education services, providing a suite of clinical resources, from the virtual classroom to the bedside. To get started, go to www.theclinx.com
From the Association for Vascular Access, this is the I SAVE That Podcast.
Ramzy: You are listening to the first ever episode of the I SAVE That Podcast from AVA. This is Ramzy Nasrallah, and joining me today from San Diego are AVA Director of Clinical Education Judy Thompson…
Judy: Hi, there!
Ramzy: …and AVA Director of Communications and Editor-in-Chief for the Journal of the Association for Vascular Access, Eric Seger.
Eric: Hi, there!
Ramzy: Lady and gentleman, how are you?
Eric: Terrific. We’re in beautiful San Diego. How could anything be bad?
Ramzy: Judy’s wearing a sweatshirt because it’s only 70 degrees.
Eric: Meanwhile, I get off the plane yesterday and am just basking in the beauty of sunlight.
Judy: Hey, it’s breezy and 70. It’s chillier than it sounds.
Eric: It’s still perfect.
Ramzy: There’s cold-blooded and then there’s being from Ohio. Which, this is balmy, for Eric at least. Later in the show, we’ll be talking with Chellie DeVries about multidisciplinary collaboration in healthcare, in a matter that produces superior outcomes. But first, this is our pilot episode. Which means we have to explain to our audience what we are doing here and why we are doing it. We’ve got a whole bunch of perspectives. Judy, ladies first – what is AVA doing? What aren’t we doing?
Judy: Oh, my goodness. We’re busy. What aren’t we doing? Truly, what aren’t we doing. It’s all over the place. We are writing guidelines, we are creating curriculum for PIV, we’re doing some special projects that are high level right now. Collaborating with other organizations, trying to get a message out that’s not from an ivory tower but it’s from the folks that do what we do.
Ramzy: The people’s tower.
Judy: The people’s tower, right. I’ve worked in organizations to where I’ve had edicts come down that say, ‘We’re going to practice in a certain manner,’ that we can’t operationalize. We’re not going to do that. We’re going to write guidelines and we’re going to write papers that help clinicians do the job. Everything with patients in mind.
Ramzy: With regard to the I SAVE That Podcast, which is being listened to for the first time ever, and hopefully not the last time ever, what do you hope to use the podcast, this broadcast, for in your world coming from AVA as the Director of Clinical Education.
Judy: Well, obviously I want to talk about some of the trending topics in vascular access.
Ramzy: Like what? What’s a trending topic in vascular access?
Judy: Oh, my goodness. The thing that’s consumed all of my time for the last three weeks is high-level disinfection. Who would have thunk that vascular access specialists need to know about high-level disinfection. Who would have thought? I don’t think we do.
Ramzy: Three weeks ago, five weeks ago, was this on your radar at all?
Judy: No. Zero.
Ramzy: But now, today, it’s consuming all of your time.
Ramzy: And this broadcast gives you the vehicle, the platform, to bring people up to your speed about why and what we’re doing around areas like high-level disinfection.
Judy: That is true. That is true. Lot more to come on that, unfortunately, for you guys right now. Because it’s a deep dive and it can be a pretty murky area down there in high-level disinfection. But it’s also something that vascular access specialists, that’s not our specialty! Unless it’s of the skin that we’re going to be putting a needle through. So, we should not be having to fiddle with that, so to speak.
Ramzy: Yet here we are.
Judy: Yet here we are. So more to come on that because it is a big deal and it could be a big deal. But we’re going to try and get in front of it for you. Couple other things: So, obviously trending topics, but a couple other things I really want to talk about that I’ve heard and read are when the IFU for a product, the instructions for use, don’t match clinically indicated to use. So, there’s a ying and yang there. So, if we say a device is good for 29 days, yet guidelines tell you not to remove and replace for fear of infection, or whatever it may be, confusion. And then we have people that want to live by the exactly 29 days. And that doesn’t compute.
Ramzy: We’ll speak directly to that, it won’t get lost in like a 39 reply Facebook thread on a page where you don’t know who’s speaking.
Judy: And you know what else I get to do? Talk about things that I am really interested in. Because I get a voice here and I get to make things up.
Ramzy: You’re allowed to be a little selfish.
Judy: I know. And I tend to be. Little bit. I’m not a proponent of 45 percent catheter-vessel ratio. I am not. I don’t believe in it. I would never almost use half of the vein of somebody I loved. So why are we saying it’s OK to use 45 percent?
Ramzy: So, we’re going to be able to talk about things like that with people who want to debate issues like cather-vessel ratio.
Judy: Yeah! I can’t wait.
Ramzy: Beautiful. That seems like it would be of value to the vascular access community.
Judy: It could. Because I think there are other people that are like me that don’t believe that using half the vein is OK.
Ramzy: And we’re going to hear from people who do.
Judy: We are.
Ramzy: I like that.
Eric: Different perspectives, different opinions.
Judy: Yeah. And the other thing is, I definitely want to hear from you guys, tell me what you want to hear about.
Ramzy: This is a show, you are our audience, but we will be soliciting feedback later in the show, it is a very easy way to do that. So that we can address what you want to hear, who you want to hear from and what you’d like us to talk about. That includes key opinion leaders, that includes practice questions, that includes Judy questions, hell you can ask Eric questions and Ramzy questions, but I would recommend you ask Judy questions because she has much better answers. Eric…
Judy: Fake it ‘til you make it.
Eric: For me, the purpose of this is to give AVA and audible voice. And what I mean by that is sharing what we stand for and what we’re working towards as an association. We’re currently doing that already on social media, with Facebook, Twitter, Instagram, LinkedIn, Pinterest – go follow us on all of those channels. But with the podcast, it’s imperative to have the audio sense. People can listen to it on their cars, on their lunch breaks or on their break during a 12-hour shift.
Ramzy: Or even if you’re driving to a patient’s house.
Eric: I think it makes us more available in that sense too. It kind of gives us a voice, which is a play on words. You know what my voice sounds like now, you know what Judy’s voice sounds like, you know what Ramzy’s voice sounds like.
Ramzy: I thought Eric Seger was like a falsetto.
Eric: A falsetto of someone who doesn’t need to talk, but that’s OK. I was just meaning…
Ramzy: A thick, British accent. Nobody would have known!
Eric: I would terrible with a British accent.
Judy: I would love to hear that. Try Australian!
Ramzy: We’ll have Australians on the show, we don’t need to hear that.
Eric: (poor Aussie accent) A little shrimp on the barbey? Oh, never again. But there are some Australians that are key opinion leaders in vascular access and we’re going to have them on the show. For those people who have been fortunate enough to travel to AVA to meet them, they’ll be able to feel closer to them, with a personal connection.
And then for me personally, with JAVA, the Journal of the Association for Vascular Access, having some authors on and doing some interviews. Giving them a platform to discuss their research, beyond just the text in a manuscript that you read in JAVA. Because that can be a little dry sometimes. And I want to give them a chance to speak on some issues they had to deal with and some hurdles that they had to go through in order to complete their research and share it with us. I think this is another vehicle and an excellent vehicle, to do that.
Ramzy: You’ve got manuscripts that you review all the time, that you coach authors on. The ones that actually get to publication, you’ll be able to tell a story and go beyond that.
Eric: The whole process. Correct.
Ramzy: I think that’s an unmet need in medicine and not just in vascular access.
Eric: It is. It’s something that I need to work towards and that’s on the plan for 2018 and beyond.
So, what about you, Ramzy? What is this for?
Ramzy: I’m glad that you asked. I’m 13 months in with AVA but like 12 years involved with AVA. I got more AVA questions in the past 13 months than I have in the 12 years combined. Which should shock you, because I’ve only worked with AVA for so long. Everyone wants to know, when I talk to them, ‘What is AVA up to? What is the Foundation doing?’ And it’s far more efficient for me to tell people on a broadcast than it is 1-on-1 in my travels. So, you were talking about being selfish and talking about things that matter to you. I like efficiency. I can speak to an audience and whenever anyone asks me something about AVA now, I can be like, ‘you should subscribe to the podcast because I talked about it then.’
Second, the I SAVE That Podcast is now one of 37 different radio shows that coalesces around vascular access, around infection prevention and patient advocacy, evidence-based medicine.
Ramzy: Just kidding. There is nothing else out there like this. We have, what in business would be called a ‘first mover’ advantage. First vascular access broadcast. We are intending to be personable, informative, entertaining. We want to fill an unmet need that you may or may not realize you had. That’s where the I SAVE That Podcast comes from.
I would be remiss if I didn’t discuss the name. In fact, I’ll throw it to you guys. How did we come to calling it the I SAVE That Podcast? What does I SAVE mean in AVA’s world?
Eric: Everything. I SAVE That Line. The I SAVE That Line campaign. Been around forever.
Judy: Been around a long time.
Eric: Been around since the late Janet Petit.
Ramzy: Right. The Godmother of AVA. Published in JAVA in 2006. The I SAVE That Line campaign, which you can learn plenty about from AVA, we have taken that brand and used it to elevate our broadcast efforts. So, the I SAVE That Podcast will be available on iTunes and other places for distribution now.
The third reason, final reason: AVA needs to be more personable. We want you to feel like AVA is your voice for vascular access, not just certain people and certain towers. We plan on having guests that speak to emerging trends in vascular access, innovation in vascular access, research that is being done and education, best practices. But also the people that are on not just the side of the bedrail where the line is being inserted but the side of the bedrail where the line is being received. This is a voice for patient advocates and patients. And also for clinical, this is a multidisciplinary organization, we are going to have a multidisciplinary broadcast. And I hope as this show evolves, we become something that’s indispensable of the vascular access specialty, where people come to this broadcast to catch up on what’s been happening.
Judy: And have fun.
Ramzy: We have to have fun. When we started pre-production on this episode, the first one, high-level disinfection wasn’t a thing. That’s how fast this stuff moves. We can capture some of this stuff as it moves, going into the air and get them in the archive. Maybe we’ll look back on this episode and be like, ‘they didn’t know what to do about high-level disinfection? How did that even happen?’
This is also a way that you can get to AVA when you’re in your car, on your way to your patient, on your way to your treatment, on your way to anywhere. Just get a little bit more about the most pervasive, invasive procedure in all of healthcare which is vascular access. That’s our intent.
When we return from the break, we will be talking with Chellie DeVries. Stay tuned.
The Clinician Exchange is the industry’s first tech-initiated crowdsourcing platform, connecting the expertise of clinicians around the world with med tech companies seeking to enhance their clinical support and educational capabilities. They’ve developed a multidisciplinary network of clinicians who want to advance healthcare by enhancing how med tech organizations interact with their customers. If you’re interested in learning more about how you can advance healthcare while getting personal incentives beyond, visit www.theclinx.com and exchange your expertise.
Ramzy: And we’re joined today by Chellie DeVries, an experienced infection control officer with a background in hospital and molecular epidemiology. She’s been an active AVA member for 6 years, a member of the Association for Professionals in Infection Control, APIC, our friends, for 22 years. She joins us today from Sharonville, Indiana, the pearl of the Hoosier State. Chellie, how are you?
Chellie: Hi Ramzy, hi Judy, hi Eric. I am fantastic. I’m so thrilled to be connecting with you guys for this.
Eric: We’re happy to have you on.
Judy: So excited. Chellie, every time I open an email these days I see your name. You are a popular girl. Love having you.
Ramzy: You’re well suited to handle the gravity of being the very first guest on the I SAVE That Podcast.
Chellie: Yeah, I’m feeling the pressure.
Judy: No pressure.
Ramzy: This is, for listeners, Chellie and I have crossed paths over the years. And even though we both are Americans and we live just a few states away from each other, I once found myself in the neighborhood where Chellie was, when I was doing some work in Dubai in United Arab Emirates. She was a quick hop over in the Kingdom of Saudi Arabia. Which is a very interesting company to go work in. I always remember our experience of trying to connect while we were there and while you were doing your road show. Can you talk a little bit about what it was like to be representing vascular access and infection control and doing your rounds in the Kingdom?
Chellie: Yeah. That was absolutely amazing. A few years back, I had an opportunity to be part of some vascular access conferences in Saudi Arabia and Kuwait. It was my first time traveling to the Middle East and having a chance to have these conversations. I went in with really no understanding of what to expect other than everything that had been portrayed in the media. And I was met and greeted with the most graciousness and open arms and people yearning to learn. It was one of the best experiences I’ve had. My biggest regret is not diving the Red Sea. But other than that, I cannot speak highly enough about the experience I had over there sharing everything we’re doing to promote patient safety in vascular access
Ramzy: They are starved for education. The appetite for what we do and what you do is through the roof. Would love to get the bandwidth to address that appetite in the near future.
Judy: Absolutely, I’d love to hear more about it at another time as well.
Ramzy: But we have some questions for you. Judy’s going to dive in.
Judy: I’m going to dive in right now. So, Chellie, collaboration around disciplines. AVA is multidisciplinary, and you’re an epidemiologist by trade. How do you see this working? I know you’ve been entrenched in our organization – thank goodness, we love having you – but how do we get bigger breadth and depth in this?
Chellie: Honestly, my first AVA conference rocked my world. And I’m not just saying that because I’m talking to you guys. For years I’ve been involved and I still am primarily as an infection preventionist to my local and regional and national conferences and I’m surrounded by other infection preventionists. Which is a wonderful way to share information. But when I went to AVA for the first time and I looked around the room and I was surrounded by clinicians of literally every flavor all working to improve patient safety and outcomes around vascular access, I was floored by just how much we could achieve by working together. It’s a stereotype where we say we shouldn’t work in silos, but sitting there at AVA, whether it’s a local meeting or the national one, realizing it’s all of us. We’re all working together, no matter what our initials are, no matter what our backgrounds are. The mountains that we’ve been able to move together is unlike anything I’ve ever experienced, truly in any other organizational collaboration.
Personally, I would love to see more of my peers in hospital infection prevention and epidemiology showing up and being actively engaged in AVA throughout all its multiple levels.
Judy: I agree with you. I couldn’t agree with you more, actually.
Ramzy: There are hospitals that are ahead of this. There are hospitals where vascular access and epidemiology are in the same department. They’re colleagues, they sit in the same meetings together. They have the same boss. It’s all tied together.
Judy: That’s really, an ideal world. Instead of having teams report to people that have no idea what the vascular access challenges are. They just report up to people that are not engaged, not passionate about what we do. I agree with you about AVA and I get excited when I get ready to go. Which is really fun.
Chellie: Judy you’ve had some of the same experiences as me. I can’t speak from a lot of the same experiences, but I can speak from a local infection prevention and vascular access groups. We have had collaborative meetings with our infection preventionists and with our KIVAN chapter where we’re all meeting together and talking about the same topics. So, certainly there are a number of infection preventionists that are very active in their local chapters. And I know you two have attended a number of the APIC chapters to really cross pollinate and share our information.
Judy: And we actually, this year, for the AVA Board we brought in an infection preventionist because we didn’t have it before.
Chellie: How cool is that? I may be biased, but…
Judy: It’s amazing. I’m very biased. We need to be tied at the hip.
Judy: Vascular access and infection prevention are in the same family. It’s crazy for them not to be tied at the hip.
Ramzy: I talked last year about creating a special interest group within AVA for vascular access and infection prevention, and I got push back, Chellie, not because it was a bad idea but because the push back was infection prevention should be the bedrock of every special interest group we do. It shouldn’t be its own.
Chellie: I would agree. I think the two are inseparable and I think they have to be. I congratulate whoever gave you the push back on that idea.
Judy: Probably you.
Ramzy: It wasn’t, but I can see Chellie doing it in a very delicate and teachable moment kind of way for me.
Judy: Couple more questions for you. Infection control and its involvement at AVA. We have kind of grabbed a couple of you guys and we have you in the heart of AVA as well. But how do we get more so we can blow the lid off of patient safety?
Chellie: Great question, Judy. I think raising awareness with everything is a starting point. Making sure all of our infection preventionists understand that it’s not an exclusive organization. We’re inclusive. So as an infection preventionist you’re not somebody on the side, you’re not an adjust member or associate, you’re fully at the table with equal standing to every other standing that is there.
We really are part of the heart of vascular access and I think just helping my peers that we’re part of AVA. We’re fully part of AVA and welcomed to be there. I think we can start by showing up at their meetings, by coming to APIC meetings and by promoting or cross promoting what’s going on in the vascular access meetings. So many, at least at the programs I’m able to participate in, is content that’s shared among both of our organizations. So, getting us together and just talking I think could go so far.
Honestly, just raising that initial awareness that we are.
Judy: You are AVA. It’s not a part. You are.
Ramzy: Infection controllers are us.
Judy: They are us. But to your point, I have been going to my San Diego chapters at APIC and I learn so much.
Chellie: Me too!
Judy: But a huge part of our San Diego Vascular Access Network is actually my APIC folks. I’m hugely appreciative of that. Because it makes us so much stronger.
Ramzy: You know, and this isn’t a gotcha question, the segment of our multidisciplinary membership that “gets it,” gets what you’re preaching about going both to APIC and AVA meetings, or being involved in all the infection control and vascular access. Do you know what segment probably has the highest amount of participation in both? It’s industry sales reps. They’re all over both. I’ve been a member of both. They see it.
Chellie: Honestly, that makes a lot of sense because they do have to be a bridge and navigate the mine fields of both of our offices.
Ramzy: You’re call points for both of them. You’re call points for them but if you work that backwards, you’re both call points because you’re both decision makers. You’re both invested in the patient outcome relative to reducing the likelihood of infection or reducing the complication of the devices. So, they need you both at the table, which means you should be at each other’s tables.
Judy: That’s true.
Chellie: Ramzy, having the opportunity to go out and work with both groups, a lot of times we are invited each other to our meetings even if we are not formal members. It’s a meet-and-greet and the shared conversations, the decisions, brainstorming, honestly the magic that happens around the table, it is really unlike anything I’ve ever seen. It’s good stuff.
Ramzy: It’s a healthy ecosystem for conversation and learning new things, versus talking to each other about stuff you all agree with already.
Judy: I know. Singing to the choir doesn’t get us very far. We have to get some people that are off tune like you and I. Well, you’re not, I am.
Chellie: Did you see we’re out of tune?
Judy: No! We’re totally, we sing like no other. Well, I’m going to go on. So, I have one last question for you before you go. You’re absolutely a data geek and I love that about you. But give me some thoughts on how you tackle data collection in vascular access. What is your dream scenario?
Chellie: Oh, that’s a loaded question, Judy.
Judy: Yeah! On purpose!
Chellie: My dream is to make recording of outcomes across all vascular access devices mandatory. If we can stop treating central lines as the only devices that matter for our patients and allow us to capture not just our complication rates across every device in our hospital…Here is what we’ve working on in my hospital. We’ve always done infection rates, but now I can tell you my complication rates across all devices my vascular access team places and by leveraging that data, we can advocate truly for the right device for the patient, not just based on standards and guidelines and literature, which are great, but what’s in line with our patients, with our inserters, with our care and maintenance. So, standardizing our data collection across every device and then standardizing it across organizations so we can truly benchmark, learn from each other and benefit the patient – that would be my happy place.
Ramzy: I’m familiar with some of your work, Chellie, where you elevated or changed the standard of catheter care for peripheral IVs, and as a result of that your central line infection rate was impacted, to your point.
Chellie: Absolutely, and thank you for that, Ramzy. We definitely have a temporal association as we improved care of our peripheral lines and our outcomes with our peripheral lines. There was a temporal association with a decrease in our ICU CLABSIs, absolutely.
And if I may do a shameless plug, I actually have a breakout, a power hour at national AVA this year talking about collection and surveillance across all of our vascular access devices. I’ll share the tools I use in my organization and some tips on how we got there because it’s something I’ve been involved in my whole career. We found ways to get it done in really an efficient manner and create that meaningful data to lead the conversations and leverage the outcomes.
Ramzy: Your session in Columbus at the AVA Scientific Meeting in September is not the most important reason to come to Columbus, it’s in the top-1,000. It’s probably in the top-5 but there’s such a long list.
Chellie: Oh my gosh, Ramzy, thank you so much! You’re so sweet.
Ramzy: I need to make everyone understand that it’s a case of thousands of VIPs of which you are on the marquee.
Judy: She’s pretty high.
Chellie: And that’s the amazing thing about AVA. There are so many brilliant things and brilliant people. Trying to find a way to do it all, it’s like a kid in a candy store.
Ramzy: It’s fun. The people you read on, you read their research, then you’re having tacos with them at lunch. You’re rubbing elbows. She is Chellie DeVries. Infection prevention has a voice, a strong voice at AVA. We’d like to see more of them. Chellie, thank you for joining us today. And now everyone who follows you has to follow you as the first-ever guest interview on the I SAVE That Podcast.
Judy: Absolutely, hard act to follow!
Eric: Way to set the bar high.
Chellie: Thank you so much guys!
Eric: If you’d like to hear our full interview with Chellie DeVries, including an intriguing segment on how her team conducts plastic rounds, you can as an AVA member benefit. Just visit avainfo.org/podcast. There you will find a link with the entire interview.
We’re going to take a short break. When we return, we’re going to hear from an author of an article coming up in the summer edition of the Journal of the Association for Vascular Access. Then a bit later, check out what’s going on at AVA, with everything from network events to the AVA Scientific Meeting and much, much more. Stay tuned.
Eric: This is the inaugural Beyond the Manuscript segment of the I SAVE That Podcast. As previously noted on the podcast, my name is Eric Seger, the Editor-in-Chief of the Journal of the Association for Vascular Access. It is my pleasure to be joined today by Donna Matocha, the author of the Continuing Education article of the JAVA summer issue, which is currently in production and due out at the beginning of June. How are you, Donna?
Donna: I am great. How are you today, Eric?
Eric: Fantastic. I heard you before that you were kind of on a little time away from the office, so I appreciate you taking the time to speak to me.
Donna: My pleasure.
Eric: Now, your article revolves around the phenomenon, the nuisance known as pump alarm fatigue within hospitals. Can you tell me a little bit about the article and how you kind of arrived at this idea for researching it?
Donna: Sure. I started working with infusion pumps as part of my job and when I went in to the doctoral program I felt that it would be a very good segment of the population to work on because it’s a big issue, this alarm fatigue. And not well studied as part of the infusion realm, but many patients get infusion therapy in the hospital, so I felt that it was an extensive population that had been overlooked.
Eric: Is this something that you have discussed with your colleagues off and on?
Donna: Yeah and I find that a lot of the nurses tend to feel that the pump is just a way of life. There are many things that occur outside of the pump that contribute to alarms that we as nurses can address to actually reduce those alarms.
Eric: What are some examples of pump alarms?
Donna: Well when we look at air in line alarms, which is a big portion of infusion alarms, a lot of it has to do with just the chemistry of the way fluids work in the environment. So if you’re looking at atmospheric pressure, as well as temperature of the fluids, that can contribute to bubble formation. We look at rates, we look at viscosities, so there are a lot of things outside of the actual hub itself.
Looking at patient side occlusion alarms, a lot of that has to do with the location of the IV set. We understand that as nurses, but we really haven’t been proactively managing that. So, I think that there’s opportunities as well.
Eric: That sounds really interesting. I’m sure that it’s some research that other infusion nurses and other clinicians in vascular access are going to be all over. Because I’m sure they’re going to say, ‘We face these sorts of things and problems in our practice as well.’
Donna: Absolutely. I think that there’s definite opportunities for learning. I don’t see it happening in nursing school, I don’t see it happening from the manufacturers, I think it’s just a very overlooked phenomenon, but it can have a very tremendous impact because patient satisfaction is definitely impacted by frequent alarms.
Eric: Absolutely, and that’s the No. 1 priority for anyone in your position. So what sort of hurdles, if there were any, did you face when you were working on your research?
Donna: I tended to want to go a little bit bigger than I had time for. I only did investigate one infusion pump, one type. I think that further researchers and other manufacturer pumps will reveal the same findings. But I can’t really say that would be true because it wasn’t studied, and I just didn’t have the time to sculpt for it.
As well as, I did find it particularly hard to find a site that was willing to study it. I think that a lot of my colleagues that were going through the program as well, finding sites to do research can be very problematic, so I think there is an opportunity for hospitals to be more willing to allow more students to come in an perform these types of projects within their facility.
Eric: Continue the education, that changes everything. I’ll get you out of here on this: What’s your hope for readers as they go through your research and read your article, what’s your hope that they take away from it to improve?
Donna: I think the best takeaway is that it improves their understanding of how these alarms work and there’s many opportunities for further information on it and really develop with a different set of knowledge and a different set of eyes for taking care of your patients. I hope that allows them to change their practice a little bit and improve the patient experience and their experience with an infusion pump.
Eric: Well I know for a fact that your article, seeing as how I edited it, is terrific, well written and there is a lot of great research in there as well. I thank you for taking the time out of your schedule to chat with me about this for the podcast. Thank you so much!
Donna: Thank you, Eric! I appreciate it.
Eric: We hope you enjoyed that interview with Donna Matocha, who graciously gave us some of her time to chat about her article on reducing infusion pump alarms through structured interventions. It is the Continuing Education for the summer issue of JAVA, which is due out in early June. I turn now back to my colleagues Ramzy and Judy – lady and gentleman, what were your impressions on what Donna had to say and what she’s doing with her research?
Judy: I thought it was great. It was informative, and we have so much alarm fatigue in what we do as clinicians that I think it was really, she’s well spoken, I think the article was great. I’m excited.
Eric: Yeah, as someone who has not been in the hospital as much as her or other clinicians like yourself, Judy, I think, well I didn’t realize that it’s sort of a phenomenon of sorts. But after reading and speaking with her it’s a big deal.
Judy: Truly – you’ve been in a hospital, right? You’ve walked down a hallway and seen lights and heard beeping.
Eric: Oh yeah. Yes, I have.
Judy: Then there’s 15 nurses sitting around and not hearing it.
Eric: They’re just used to it.
Judy: Yeah, it’s hard on patients and families.
Ramzy: Clinicians learn to tune those things out, whereas for patients, beeping is bad.
Judy: Beeping is bad. It’s scary, or it’s uncomfortable.
Ramzy: The poster fatigue, the alarm fatigue, that’s all very real. Later on in this season we’ll be talking about some pretty bold new initiatives that AVA is creating and deploying specifically to attack the way we look at crises in hospitals. Not just making louder beeps and lights but changing how we address them. That’s a teaser for the rest of the season.
Eric: Some great interviews in this episode here I think with both Chellie and Donna.
Judy: I agree. That was fun with Chellie. Boy, could she keep a conversation going. She always has something either controversial, groundbreaking or just pure fun to talk about.
So, Eric, I have a question: How do I subscribe to our own podcast?
Eric: For those of you who are like Judy and aren’t sure how to find us and find this podcast, if you are an Apple customer, you can open your iTunes and it is incredibly easy. Open iTunes on your laptop or your tablet and type I SAVE That Podcast in the search bar, which is located in the top right-hand corner. Then once you’re on the I SAVE That Podcast page, you’ll see our logo and everything there, you simply click the subscribe button and voila! All the new episodes of our podcast will download immediately to your iTunes when they become available.
You can do that on your iPhone too. There is a podcast app, and then again you just search for I SAVE That Podcast and click on subscribe once you arrive at our page. For Android users, which I am not one of those but I understand that they now have the Google Play music app and you can hit the menu button, tap search and again search for I SAVE That Podcast. Then once you’re on the page you click subscribe. It’s pretty easy and straightforward.
AVA is available to you also on all social media platforms, everywhere, which is where we provide vascular access news, updates and research on a daily basis. On Twitter you can find us @ISaveThatLine, you can like us Facebook at Association for Vascular Access, follow us on Instagram @i_save_that_line, and you can follow us on LinkedIn @associationforvascularaccess and you can do the same on Pinterest, that’s one of our newest social media platforms that we’ve joined. Just search for ‘Association for Vascular Access.’
And while you’re at it, you can like the AVA Foundation on Facebook and follow it on LinkedIn because as the three of us know, there are countless great things coming from AVA. That’s it for us this week on the I SAVE That Podcast. Thanks for listening! Be sure to subscribe to us on iTunes, you can find us on SoundCloud and Spotify as well. We’ll see you next time!
Please subscribe to the show and share it with your friends and colleagues because we have a whole bunch of great guests lined up for future episodes, including LeBron James, Sandra Bullock, Oprah Winfrey, Dr. Hudson Garrett and Dr. Vineet Chopra. A few of those are not yet confirmed but they’ve all been invited.
Thank you to The Clinician Exchange again for sponsoring this first episode. Thank you, Chellie DeVries, thank you Dabney Coleman and we will see you next time.